NSPR · InspireMD Inc. Common Stock
View on chartInsiders & Stakes
| Marvin Slosman CEO and President | ▲ Buy | Open Market | 3,556,658 Shares held | 5/12/2026 | View profile |
| Shore Craig CFO and CAO | ▲ Buy | Grant | 1,112,460 Shares held | 1/7/2025 | View profile |
| Shane Thomas Gleason VP Global Marketing | ▼ Sell | Open Market | 1,053,882 Shares held | 5/19/2026 | View profile |
| Andrea Tommasoli Chief Operating Officer | ▲ Buy | Grant | 954,389 Shares held | 1/14/2026 | View profile |
| Gary S. Roubin Director | ▲ Buy | Open Market | 834,478 Shares held | 5/7/2026 | View profile |
| Michael A. Lawless Chief Financial Officer | ▲ Buy | Grant | 691,695 Shares held | 1/14/2026 | View profile |
| Paul Stuka Director | ▲ Buy | Open Market | 667,871 Shares held | 5/27/2026 | View profile |
| Thomas J. Kester Director | ▲ Buy | Grant | 458,573 Shares held | 9/15/2025 | View profile |
| Michael Berman Director | ▲ Buy | Grant | 352,586 Shares held | 1/14/2026 | View profile |
| Verta Patrick EVP Clinical/Medical Affairs | ▲ Buy | Grant | 311,532 Shares held | 1/7/2025 | View profile |
| Kathryn Arnold Director | ▲ Buy | Grant | 303,087 Shares held | 12/30/2025 | View profile |
| Scott R. Ward Director | ▲ Buy | Open Market | 237,096 Shares held | 5/7/2026 | View profile |
| Danny L. Dearen Director | ▲ Buy | Grant | 102,047 Shares held | 1/14/2026 | View profile |
| Raymond W. Cohen Director | ▲ Buy | Grant | 92,417 Shares held | 1/14/2026 | View profile |
| Campbell Rogers Director | ▲ Buy | Grant | 27,960 Shares held | 10/13/2021 | View profile |
Transaction History
| Paul Stuka | ▲ Buy | Open Market | 20,000 | $18K | 5/27/2026 |
| Shane Thomas Gleason | ▼ Sell | Open Market | 22,778 | $23K | 5/19/2026 |
| Paul Stuka | ▲ Buy | Open Market | 5,000 | $6K | 5/14/2026 |
| Paul Stuka | ▲ Buy | Open Market | 10,000 | $12K | 5/13/2026 |
| Marvin Slosman | ▲ Buy | Open Market | 21,000 | $25K | 5/12/2026 |
| Paul Stuka | ▲ Buy | Open Market | 10,000 | $12K | 5/11/2026 |
| Paul Stuka | ▲ Buy | Open Market | 65,626 | $76K | 5/8/2026 |
| Scott R. Ward | ▲ Buy | Open Market | 73,255 | $84K | 5/7/2026 |
| Gary S. Roubin | ▲ Buy | Open Market | 90,000 | $106K | 5/7/2026 |
| Paul Stuka | ▲ Buy | Open Market | 6,378 | $7K | 5/7/2026 |
| Scott R. Ward | ▲ Buy | Open Market | 15,995 | $18K | 5/6/2026 |
| Paul Stuka | ▲ Buy | Open Market | 1,517 | $2K | 5/6/2026 |
| Shane Thomas Gleason | ▼ Sell | Open Market | 2,941 | $5K | 2/2/2026 |
| Shane Thomas Gleason | ▼ Sell | Open Market | 2,000 | $3K | 2/2/2026 |
| Shane Thomas Gleason | ▼ Sell | Open Market | 2,900 | $5K | 1/30/2026 |
| Shane Thomas Gleason | ▼ Sell | Open Market | 5,000 | $8K | 1/29/2026 |
| Shane Thomas Gleason | ▼ Sell | Open Market | 12,395 | $20K | 1/28/2026 |
| Shane Thomas Gleason | ▼ Sell | Open Market | 4,781 | $8K | 1/27/2026 |
| Shane Thomas Gleason | ▼ Sell | Open Market | 8,411 | $13K | 1/22/2026 |
| Shane Thomas Gleason | ▼ Sell | Open Market | 17,593 | $29K | 1/21/2026 |
| Shane Thomas Gleason | ▼ Sell | Open Market | 2,955 | $5K | 1/20/2026 |
| Shane Thomas Gleason | ▼ Sell | Open Market | 2,250 | $4K | 1/16/2026 |
| Shane Thomas Gleason | ▼ Sell | Open Market | 2,909 | $5K | 1/15/2026 |
| Scott R. Ward | ▲ Buy | Grant | 88,053 | $0 | 1/14/2026 |
| Andrea Tommasoli | ▲ Buy | Grant | 226,695 | $0 | 1/14/2026 |
| Raymond W. Cohen | ▲ Buy | Grant | 44,030 | $0 | 1/14/2026 |
| Michael Berman | ▲ Buy | Grant | 88,053 | $0 | 1/14/2026 |
| Paul Stuka | ▲ Buy | Grant | 132,076 | $0 | 1/14/2026 |
| Marvin Slosman | ▲ Buy | Grant | 1,114,792 | $0 | 1/14/2026 |
| Gary S. Roubin | ▲ Buy | Grant | 88,053 | $0 | 1/14/2026 |
| Michael A. Lawless | ▲ Buy | Grant | 226,695 | $0 | 1/14/2026 |
| Shane Thomas Gleason | ▲ Buy | Grant | 453,390 | $0 | 1/14/2026 |
| Danny L. Dearen | ▲ Buy | Grant | 44,030 | $0 | 1/14/2026 |
| Kathryn Arnold | ▲ Buy | Grant | 55,556 | $0 | 12/30/2025 |
| Paul Stuka | ▲ Buy | Open Market | 5,073 | $9K | 12/9/2025 |
| Paul Stuka | ▲ Buy | Open Market | 5,073 | $9K | 12/5/2025 |
| Paul Stuka | ▲ Buy | Open Market | 10,130 | $19K | 12/4/2025 |
| Paul Stuka | ▲ Buy | Open Market | 13,431 | $22K | 11/12/2025 |
| Gary S. Roubin | ▲ Buy | Grant | 48,000 | $0 | 10/7/2025 |
| Thomas J. Kester | ▲ Buy | Grant | 37,815 | $0 | 9/15/2025 |
| Paul Stuka | ▲ Buy | Open Market | 20,661 | $50K | 7/30/2025 |
| Marvin Slosman | ▲ Buy | Open Market | 10,330 | $25K | 7/30/2025 |
| Gary S. Roubin | ▲ Buy | Open Market | 41,322 | $100K | 7/30/2025 |
| Thomas J. Kester | ▲ Buy | Open Market | 30,991 | $75K | 7/30/2025 |
| Thomas J. Kester | ▼ Sell | Other | 30,624 | $42K | 7/11/2025 |
| Paul Stuka | ▼ Sell | Other | 87,500 | $121K | 7/1/2025 |
| Michael Berman | ▼ Sell | Other | 61,248 | $85K | 6/29/2025 |
| Gary S. Roubin | ▼ Sell | Other | 30,624 | $42K | 6/25/2025 |
| Shane Thomas Gleason | ▼ Sell | Open Market | 7,186 | $18K | 5/30/2025 |
| Shane Thomas Gleason | ▼ Sell | Open Market | 3,760 | $9K | 5/29/2025 |
| Shane Thomas Gleason | ▼ Sell | Open Market | 1,572 | $4K | 5/27/2025 |
| Shane Thomas Gleason | ▼ Sell | Open Market | 2,482 | $6K | 5/23/2025 |
| Shane Thomas Gleason | ▼ Sell | Open Market | 10,000 | $37K | 2/25/2025 |
| Shane Thomas Gleason | ▼ Sell | Open Market | 5,132 | $13K | 2/4/2025 |
| Shane Thomas Gleason | ▼ Sell | Open Market | 7,073 | $18K | 2/3/2025 |
| Shane Thomas Gleason | ▼ Sell | Open Market | 9,923 | $25K | 1/31/2025 |
| Shane Thomas Gleason | ▼ Sell | Open Market | 2,454 | $6K | 1/30/2025 |
| Shane Thomas Gleason | ▼ Sell | Open Market | 3,660 | $9K | 1/29/2025 |
| Shane Thomas Gleason | ▼ Sell | Open Market | 2,476 | $6K | 1/28/2025 |
| Shane Thomas Gleason | ▼ Sell | Open Market | 3,858 | $10K | 1/27/2025 |
| Andrea Tommasoli | ▲ Buy | Grant | 232,616 | $0 | 1/7/2025 |
| Scott R. Ward | ▲ Buy | Grant | 16,245 | $0 | 1/7/2025 |
| Kathryn Arnold | ▲ Buy | Grant | 32,491 | $0 | 1/7/2025 |
| Thomas J. Kester | ▲ Buy | Grant | 32,491 | $0 | 1/7/2025 |
| Gary S. Roubin | ▲ Buy | Grant | 32,491 | $0 | 1/7/2025 |
| Marvin Slosman | ▲ Buy | Grant | 558,417 | $0 | 1/7/2025 |
| Paul Stuka | ▲ Buy | Grant | 48,736 | $0 | 1/7/2025 |
| Shane Thomas Gleason | ▲ Buy | Grant | 232,616 | $0 | 1/7/2025 |
| Michael Berman | ▲ Buy | Grant | 32,491 | $0 | 1/7/2025 |
| Shore Craig | ▲ Buy | Grant | 232,616 | $0 | 1/7/2025 |
| Verta Patrick | ▲ Buy | Grant | 83,072 | $0 | 1/7/2025 |
| Michael Berman | ▼ Sell | Other | 61,249 | $85K | 6/24/2024 |
| Paul Stuka | ▼ Sell | Other | 87,500 | $121K | 6/5/2024 |
| Thomas J. Kester | ▼ Sell | Other | 30,625 | $42K | 5/28/2024 |
| Gary S. Roubin | ▼ Sell | Other | 30,625 | $42K | 5/28/2024 |
| Thomas J. Kester | ▲ Buy | Grant | 29,032 | $0 | 1/23/2024 |
| Verta Patrick | ▲ Buy | Grant | 85,720 | $0 | 1/23/2024 |
| Shane Thomas Gleason | ▲ Buy | Grant | 238,625 | $0 | 1/23/2024 |
| Andrea Tommasoli | ▲ Buy | Grant | 238,625 | $0 | 1/23/2024 |
| Kathryn Arnold | ▲ Buy | Grant | 29,032 | $0 | 1/23/2024 |
| Shore Craig | ▲ Buy | Grant | 238,625 | $0 | 1/23/2024 |
| Gary S. Roubin | ▲ Buy | Grant | 29,032 | $0 | 1/23/2024 |
| Marvin Slosman | ▲ Buy | Grant | 563,499 | $0 | 1/23/2024 |
| Paul Stuka | ▲ Buy | Grant | 43,548 | $0 | 1/23/2024 |
| Michael Berman | ▲ Buy | Grant | 29,032 | $0 | 1/23/2024 |
| Gary S. Roubin | ▲ Buy | Grant | 3,229 | $0 | 1/2/2024 |
| Michael Berman | ▲ Buy | Grant | 3,782 | $0 | 1/2/2024 |
| Kathryn Arnold | ▲ Buy | Grant | 1,661 | $0 | 1/2/2024 |
| Thomas J. Kester | ▲ Buy | Grant | 3,183 | $0 | 1/2/2024 |
| Gary S. Roubin | ▲ Buy | Open Market | 50,000 | $127K | 11/30/2023 |
| Michael Berman | ▲ Buy | Grant | 3,106 | $0 | 10/2/2023 |
| Kathryn Arnold | ▲ Buy | Grant | 1,364 | $0 | 10/2/2023 |
| Gary S. Roubin | ▲ Buy | Grant | 2,652 | $0 | 10/2/2023 |
| Thomas J. Kester | ▲ Buy | Grant | 2,614 | $0 | 10/2/2023 |
| Shane Thomas Gleason | ▲ Buy | Grant | 19,290 | $0 | 8/28/2023 |
| Gary S. Roubin | ▲ Buy | Grant | 3,445 | $0 | 7/1/2023 |
| Thomas J. Kester | ▲ Buy | Grant | 3,396 | $0 | 7/1/2023 |
| Michael Berman | ▲ Buy | Grant | 4,351 | $0 | 7/1/2023 |
| Kathryn Arnold | ▲ Buy | Grant | 1,772 | $0 | 7/1/2023 |
| Paul Stuka | ▲ Buy | Grant | 225,680 | $0 | 5/17/2023 |
| Shane Thomas Gleason | ▲ Buy | Grant | 256,450 | $0 | 5/17/2023 |
| Gary S. Roubin | ▲ Buy | Grant | 149,260 | $0 | 5/17/2023 |
| Marvin Slosman | ▲ Buy | Grant | 1,045,150 | $0 | 5/17/2023 |
| Shore Craig | ▲ Buy | Grant | 522,580 | $0 | 5/17/2023 |
| Michael Berman | ▲ Buy | Grant | 149,260 | $0 | 5/17/2023 |
| Andrea Tommasoli | ▲ Buy | Grant | 179,080 | $0 | 5/17/2023 |
| Thomas J. Kester | ▲ Buy | Grant | 149,260 | $0 | 5/17/2023 |
| Kathryn Arnold | ▲ Buy | Grant | 149,260 | $0 | 5/17/2023 |
| Paul Stuka | ▲ Buy | Open Market | 175,000 | $286K | 5/12/2023 |
| Thomas J. Kester | ▲ Buy | Open Market | 61,249 | $100K | 5/12/2023 |
| Michael Berman | ▲ Buy | Open Market | 122,497 | $200K | 5/12/2023 |
| Gary S. Roubin | ▲ Buy | Open Market | 61,249 | $100K | 5/12/2023 |
| Gary S. Roubin | ▲ Buy | Grant | 8,102 | $0 | 4/1/2023 |
| Michael Berman | ▲ Buy | Grant | 9,491 | $0 | 4/1/2023 |
| Thomas J. Kester | ▲ Buy | Grant | 7,986 | $0 | 4/1/2023 |
| Kathryn Arnold | ▲ Buy | Grant | 4,167 | $0 | 4/1/2023 |
| Gary S. Roubin | ▲ Buy | Open Market | 35,500 | $68K | 8/18/2022 |
| Gary S. Roubin | ▲ Buy | Open Market | 16,393 | $50K | 12/28/2021 |
| Paul Stuka | ▲ Buy | Open Market | 12,037 | $42K | 12/1/2021 |
| Paul Stuka | ▲ Buy | Open Market | 18,372 | $65K | 11/30/2021 |
| Paul Stuka | ▲ Buy | Open Market | 3,177 | $11K | 11/29/2021 |
| Paul Stuka | ▲ Buy | Open Market | 1,200 | $4K | 11/26/2021 |
| Paul Stuka | ▲ Buy | Open Market | 18,328 | $65K | 11/24/2021 |
| Paul Stuka | ▲ Buy | Open Market | 1,204 | $4K | 11/23/2021 |
| Paul Stuka | ▲ Buy | Open Market | 19,188 | $68K | 11/22/2021 |
| Gary S. Roubin | ▲ Buy | Open Market | 25,640 | $99K | 11/17/2021 |
| Gary S. Roubin | ▲ Buy | Open Market | 290 | $1K | 11/17/2021 |
| Michael Berman | ▲ Buy | Grant | 17,248 | $0 | 11/10/2021 |
| Shore Craig | ▲ Buy | Grant | 72,978 | $0 | 11/10/2021 |
| Thomas J. Kester | ▲ Buy | Grant | 17,248 | $0 | 10/13/2021 |
| Paul Stuka | ▲ Buy | Grant | 26,079 | $0 | 10/13/2021 |
| Kathryn Arnold | ▲ Buy | Grant | 17,248 | $0 | 10/13/2021 |
| Marvin Slosman | ▲ Buy | Grant | 146,567 | $0 | 10/13/2021 |
| Gary S. Roubin | ▲ Buy | Grant | 17,248 | $0 | 10/13/2021 |
| Campbell Rogers | ▲ Buy | Grant | 17,248 | $0 | 10/13/2021 |
| Gary S. Roubin | ▲ Buy | Open Market | 22,249 | $93K | 8/25/2021 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
InspireMD (NSPR) noted in pre‑market health‑care stock moves
NSPR was listed among twelve health‑care companies showing price action in Friday’s pre‑market session, according to Benzinga. The move comes while the stock’s RSI is low at 25.7 and it is near its $0.70 support level, suggesting continued pressure. Such activity may reflect renewed trader attention despite the broader market context.
InspireMD (NSPR) noted in pre‑market health‑care stock moves. NSPR was listed among twelve health‑care companies showing price action in Friday’s pre‑market session, according to Benzinga. The move comes while the stock’s RSI is low at 25.7 and it is near its $0.70 support level, suggesting continued pressure. Such activity may reflect renewed trader attention despite the broader market context.